Pharmaceutical giant Pfizer is facing a large amount of lawsuits from women who claim that the firm was aware that its anti-cholesterol drug Lipitor was causing possible serious side ... Read More
The US pharmaceutical seeking to acquire UK rival AstraZeneca represents a tax avoidance risk, according to the UK druggist’s chief executive Pascal Soriot. Pfizer, which has proposed a £63bn ... Read More
U.S. pharmaceuticals company Pfizer has augmented its attempt to buy AstraZeneca, the U.K.’s second-biggest drug maker, with a letter to Prime Minister David Cameron. The missive, as well as ... Read More
Pfizer Inc. (PFE) sweetened its bid for AstraZeneca Plc (AZN) to about 63.1 billion pounds ($106.5 billion), aiming to bring the U.K.’s second-biggest drugmaker to the negotiating table. The ... Read More
We use cookies to improve your browsing experience on our website. To find out more, please read our Privacy Policy and Cookies Policy, been updated and became effective May 24, 2018.
By continuing to navigate our website without changing your cookies settings, or by clicking 'Ok', you hereby acknowledge and agree to OneStopBrokers use of cookies.OkRead more